You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
AstraZeneca
Medtronic
Boehringer Ingelheim
Moodys

Last Updated: March 29, 2020

DrugPatentWatch Database Preview

Drug Sales Trends for RANEXA


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for RANEXA (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $387,680,703
INSIDE ANOTHER STORE $69,962,001
[disabled in preview] $420,045,334
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 386,818
INSIDE ANOTHER STORE 202,032
[disabled in preview] 794,650
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $27,581,278
MEDICARE $573,942,186
[disabled in preview] $276,164,574
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for RANEXA
Drug Units Sold Trends for RANEXA

Annual Sales Revenues and Units Sold for RANEXA

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
RANEXA   Start Trial   Start Trial 2017
RANEXA   Start Trial   Start Trial 2016
RANEXA   Start Trial   Start Trial 2015
RANEXA   Start Trial   Start Trial 2014
RANEXA   Start Trial   Start Trial 2013
RANEXA   Start Trial   Start Trial 2012
RANEXA   Start Trial   Start Trial 2011
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.